Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2

Clinical trial NCT02526485 · COMPLETED

Trial details

NCT number: NCT02526485
Sponsor: Vanderbilt University Medical Center
Status: COMPLETED
Study type: OBSERVATIONAL

Heparin-induced Thrombocytopenia

Start date: 2015-03-01
Primary completion: 2018-09-05
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.